Kevin Moulder

Person

Cambridge, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of antagonizing the binding of CD40 to CD40L with CD40L-spe...
- Patent number 8,524,236
- Issue date Sep 3, 2013
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of antagonizing binding of CD40 to CD40L with CD40L-specifi...
- Patent number 7,927,596
- Issue date Apr 19, 2011
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD40L-specific monovalent polypeptides
- Patent number 7,829,096
- Issue date Nov 9, 2010
- Domantis Ltd.
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monovalent anti-CD40L antibody polypeptides and compositions thereof
- Patent number 7,563,443
- Issue date Jul 21, 2009
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LIGAND
- Publication number 20150087813
- Publication date Mar 26, 2015
- Domantis Limited
- Kevin Moulder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE
- Publication number 20110172400
- Publication date Jul 14, 2011
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ligand
- Publication number 20100234570
- Publication date Sep 16, 2010
- Domantis Limited
- Kevin Moulder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20100092483
- Publication date Apr 15, 2010
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20100092482
- Publication date Apr 15, 2010
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ligand
- Publication number 20100081792
- Publication date Apr 1, 2010
- SmithKline Beecham Corporation
- Steven Grant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20090297524
- Publication date Dec 3, 2009
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ligand that has binding specificity for IL-4 and/or lL-13
- Publication number 20080233129
- Publication date Sep 25, 2008
- Ian M. Tomlinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ligand that has binding specificity for IL-4 and/or IL-13
- Publication number 20080233130
- Publication date Sep 25, 2008
- Ian M. Tomlinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ligand that has binding specificity for IL-4 and/or IL-13
- Publication number 20070104710
- Publication date May 10, 2007
- Domants Limited
- Ian M. Tomlinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ligand
- Publication number 20070093651
- Publication date Apr 26, 2007
- Domantis Limited
- Kevin Moulder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ligand
- Publication number 20060063921
- Publication date Mar 23, 2006
- Domantis Limited
- Kevin Moulder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20060062784
- Publication date Mar 23, 2006
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY

Kevin Moulder

Person

Patents Grantslast 30 patents

Methods of antagonizing the binding of CD40 to CD40L with CD40L-spe...

Methods of antagonizing binding of CD40 to CD40L with CD40L-specifi...

CD40L-specific monovalent polypeptides

Monovalent anti-CD40L antibody polypeptides and compositions thereof

Patents Applicationslast 30 patents

LIGAND

COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE

Ligand

Compositions monovalent for CD40L binding and methods of use

Compositions monovalent for CD40L binding and methods of use

Ligand

Compositions monovalent for CD40L binding and methods of use

Ligand that has binding specificity for IL-4 and/or lL-13

Ligand that has binding specificity for IL-4 and/or IL-13

Ligand that has binding specificity for IL-4 and/or IL-13

Ligand

Ligand

Compositions monovalent for CD40L binding and methods of use